Analysts' Opinions Are Mixed on These Healthcare Stocks: Haleon PLC (GB:HLN) and Stoke Therapeutics (STOK)
Haleon Analyst Ratings
Morgan Stanley Initiates Coverage On Haleon With Overweight Rating, Announces Price Target of $9
Haleon Analyst Ratings
Credit Suisse Lifts Price Target on Haleon to GBP3.90 From GBP3.72 on 'Strong' Underlying Trends, Pricing; Outperform Rating Kept
Argus Research Upgrades Haleon to Buy, Announces $10 Price Target
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), UnitedHealth (UNH) and Haleon PLC Sponsored ADR (HLN)
No Data